Protalex Inc.
145 Union Square Drive
New Hope,
PA 18938
United States - Map
Phone: 215-862-9720
Fax: 215-862-6614
Web Site: http://www.protalex.com
| Protalex, Inc., a development stage company, engages in the development of biopharmaceutical drugs for the treatment of autoimmune and inflammatory diseases in the United States. The company targets the autoimmune diseases rheumatoid arthritis and idiopathic thrombocytopenic purpura. Its lead compound, PRTX-100, is a purified form of the Staphylococcal bacterial protein known as Protein A that has the ability to bind to and to down regulate activation of human B-lymphocytes and macrophages, which are key cells mediating inflammation in certain autoimmune diseases. The company was founded in 1999 and is headquartered in New Hope, Pennsylvania. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Arnold P. Kling , 51
Pres |
N/A
| N/A | Mr. Kirk M. Warshaw CPA, 51
Chief Financial Officer, Sec. |
N/A
| N/A | Mr. Marc L. Rose C.P.A., 45
Chief Financial Officer, Principal Accounting Officer, VP of Fin., Corp. Sec. and Treasurer |
N/A
|
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.11% Nasdaq 
Profile
